Innovating Simpler and Less Toxic Frontline Management for Adults With ALL
- PMID: 37883737
- DOI: 10.1200/JCO.23.01726
Innovating Simpler and Less Toxic Frontline Management for Adults With ALL
Similar articles
-
Early T-Cell Precursor Leukemia: A High-Risk Subtype of Acute Lymphoblastic Leukemia, Single Center Experience in Jordan.Clin Lymphoma Myeloma Leuk. 2023 Nov;23(11):e411-e419. doi: 10.1016/j.clml.2023.08.007. Epub 2023 Sep 6. Clin Lymphoma Myeloma Leuk. 2023. PMID: 37730482
-
Monoclonal antibodies in frontline therapy of adult acute lymphoblastic leukemia: A step ahead.Med Clin (Barc). 2022 May 27;158(10):476-477. doi: 10.1016/j.medcli.2022.01.007. Epub 2022 Feb 19. Med Clin (Barc). 2022. PMID: 35193761 English, Spanish. No abstract available.
-
The evolution of frontline therapy for adult Philadelphia-positive acute lymphoblastic leukemia: Giant strides and ongoing challenges.Am J Hematol. 2023 Mar;98(3):374-376. doi: 10.1002/ajh.26813. Epub 2022 Dec 31. Am J Hematol. 2023. PMID: 36540957 No abstract available.
-
[Current management of adult acute lymphoblastic leukemia/lymphoma].Rinsho Ketsueki. 2011 Oct;52(10):1594-602. Rinsho Ketsueki. 2011. PMID: 21971236 Review. Japanese. No abstract available.
-
[Treatment strategies for acute lymphoblastic leukemia in adults].Nihon Rinsho. 2007 Jan 28;65 Suppl 1:474-8. Nihon Rinsho. 2007. PMID: 17474450 Review. Japanese. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
